Updated epidemiology of gastrointestinal cancers in East Asia.
Journal
Nature reviews. Gastroenterology & hepatology
ISSN: 1759-5053
Titre abrégé: Nat Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101500079
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
accepted:
29
11
2022
medline:
1
5
2023
pubmed:
12
1
2023
entrez:
11
1
2023
Statut:
ppublish
Résumé
Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence and one-third of cancer-related mortality. Although there has been much progress in screening colorectal cancer, the prognosis of other gastrointestinal cancers tends to be poor. The highest burden of gastrointestinal cancers, including stomach, liver, oesophageal and gallbladder cancers, was observed in regions in East Asia. The increasing burden of gastrointestinal cancers in East Asian regions is related to population growth, ageing and the westernization of lifestyle habits in this region. Furthermore, the rising incidence of young-onset colorectal cancer is an emerging trend in East Asia. This Review provides a comprehensive and updated summary of the epidemiology of gastrointestinal cancers in East Asia, with emphasis on comparing their epidemiology in East Asia with that in Western regions, and highlights the major risk factors and implications for prevention. Overall, to optimally reduce the disease burden incurred by gastrointestinal cancers in East Asian regions, a concerted effort will be needed to modify unhealthy lifestyles, promote vaccination against the hepatitis virus, control Helicobacter pylori, liver fluke and hepatitis virus infections, increase the uptake rate of colorectal cancer screening, enhance detection of early cancers and their precursors, and improve cancer survivorship through an organized rehabilitation programme.
Identifiants
pubmed: 36631716
doi: 10.1038/s41575-022-00726-3
pii: 10.1038/s41575-022-00726-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
271-287Informations de copyright
© 2023. Springer Nature Limited.
Références
Arnold, M. et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159, 335–349.e15 (2020).
pubmed: 32247694
doi: 10.1053/j.gastro.2020.02.068
Allemani, C. et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391, 1023–1075 (2018).
pubmed: 29395269
pmcid: 5879496
doi: 10.1016/S0140-6736(17)33326-3
Arnold, M. et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 20, 1493–1505 (2019).
pubmed: 31521509
pmcid: 6838671
doi: 10.1016/S1470-2045(19)30456-5
Huang, J. et al. Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology 160, 744–754 (2021).
pubmed: 33058868
doi: 10.1053/j.gastro.2020.10.007
Huang, J. et al. Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis. Cancer Lett. 521, 238–251 (2021).
pubmed: 34506845
doi: 10.1016/j.canlet.2021.09.004
Pourhoseingholi, M. A., Vahedi, M. & Baghestani, A. R. Burden of gastrointestinal cancer in Asia; an overview. Gastroenterol. Hepatol. Bed Bench 8, 19–27 (2015).
pubmed: 25584172
pmcid: 4285928
International Agency for Research on Cancer. Cancer tomorrow. The Global Cancer Observatory https://gco.iarc.fr/tomorrow (2020).
Xie, Y., Shi, L., He, X. & Luo, Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol. Rep. 9, 91–104 (2021).
doi: 10.1093/gastro/goab010
United Nations. World population ageing. United Nations https://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf (2017).
Ezzati, M. & Riboli, E. Behavioral and dietary risk factors for noncommunicable diseases. N. Engl. J. Med. 369, 954–964 (2013).
pubmed: 24004122
doi: 10.1056/NEJMra1203528
Akimoto, N. et al. Rising incidence of early-onset colorectal cancer-a call to action. Nat. Rev. Clin. Oncol. 18, 230–243 (2021).
pubmed: 33219329
doi: 10.1038/s41571-020-00445-1
Wong, M. C. S. et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin. Gastroenterol. Hepatol. 19, 955–966.e61 (2021).
pubmed: 32088300
doi: 10.1016/j.cgh.2020.02.026
Wolf, A. M. D. et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J. Clin. 68, 250–281 (2018).
pubmed: 29846947
doi: 10.3322/caac.21457
US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 325, 1965–1977 (2021).
doi: 10.1001/jama.2021.6238
Sung, J. J. Y. et al. Increasing trend in young-onset colorectal cancer in Asia: more cancers in men and more rectal cancers. Am. J. Gastroenterol. 114, 322–329 (2019).
pubmed: 30694865
doi: 10.14309/ajg.0000000000000133
Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H. & Boland, C. R. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol. Hepatol. 7, 262–274 (2022).
pubmed: 35090605
doi: 10.1016/S2468-1253(21)00426-X
International Agency for Research on Cancer. Cancer today. The Global Cancer Observatory https://gco.iarc.fr/today/home (2020).
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
pubmed: 33538338
doi: 10.3322/caac.21660
Sunkara, V. & Hébert, J. R. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care. Cancer 121, 1563–1569 (2015).
pubmed: 25572676
doi: 10.1002/cncr.29228
Adams, S. A. et al. Decreased cancer mortality-to-incidence ratios with increased accessibility of federally qualified health centers. J. Community Health 40, 633–641 (2015).
pubmed: 25634545
pmcid: 4490935
doi: 10.1007/s10900-014-9978-8
Choi, E. et al. Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries. Epidemiol. Health 39, e2017006 (2017).
pubmed: 28171715
pmcid: 5434228
doi: 10.4178/epih.e2017006
Institute for Health Metrics and Evaluation. GBD results. Institute for Health Metrics and Evaluation https://vizhub.healthdata.org/gbd-results/ (2021).
GBD 2019 Colorectal Cancer Collaborators. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol. 7, 627–647 (2022).
doi: 10.1016/S2468-1253(22)00044-9
GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 4, 934–947 (2019).
doi: 10.1016/S2468-1253(19)30347-4
Popkin, B. M., Adair, L. S. & Ng, S. W. Global nutrition transition and the pandemic of obesity in developing countries. Nutr. Rev. 70, 3–21 (2012).
pubmed: 22221213
doi: 10.1111/j.1753-4887.2011.00456.x
Faruque, S. et al. The dose makes the poison: sugar and obesity in the United States–a review. Pol. J. Food Nutr. Sci. 69, 219–233 (2019).
pubmed: 31938015
pmcid: 6959843
doi: 10.31883/pjfns/110735
World Health Organization. Obesity and overweight. WHO https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight (2020).
Mills, K. T. et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 134, 441–450 (2016).
pubmed: 27502908
pmcid: 4979614
doi: 10.1161/CIRCULATIONAHA.115.018912
Navarro, M., Nicolas, A., Ferrandez, A. & Lanas, A. Colorectal cancer population screening programs worldwide in 2016: an update. World J. Gastroenterol. 23, 3632–3642 (2017).
pubmed: 28611516
pmcid: 5449420
doi: 10.3748/wjg.v23.i20.3632
Levin, T. R. et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology 155, 1383–1391.e5 (2018).
pubmed: 30031768
doi: 10.1053/j.gastro.2018.07.017
Siegel, R. L. et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J. Natl Cancer Inst. 109, djw322 (2017).
pubmed: 28376186
pmcid: 6059239
doi: 10.1093/jnci/djw322
Murphy, C. C. et al. Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population-based screening. Clin. Gastroenterol. Hepatol. 15, 903–909.e6 (2017).
pubmed: 27609707
doi: 10.1016/j.cgh.2016.08.037
Gu, M. & Thapa, S. Colorectal cancer in the United States and a review of its heterogeneity among Asian American subgroups. Asia Pac. J. Clin. Oncol. 16, 193–200 (2020).
pubmed: 32129941
doi: 10.1111/ajco.13324
European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67, 789–804 (2018).
doi: 10.1136/gutjnl-2018-316027
Mukewar, S. & Chari, S. T. in The Pancreas: an Integrated Textbook of Basic Science, Medicine, and Surgery 3rd edn (eds Beger, H. G. et al.) 565–572 (Wiley, 2018).
Wu, H. et al. Advances in biomarkers and techniques for pancreatic cancer diagnosis. Cancer Cell Int. 22, 220 (2022).
pubmed: 35761336
pmcid: 9237966
doi: 10.1186/s12935-022-02640-9
Huang, J. et al. Disease burden, risk factors, and recent trends of liver cancer: a global country-level analysis. Liver Cancer 10, 330–345 (2021).
pubmed: 34414121
pmcid: 8339459
doi: 10.1159/000515304
Codipilly, D. C. et al. Epidemiology and outcomes of young-onset esophageal adenocarcinoma: an analysis from a population-based database. Cancer Epidemiol. Biomark. Prev. 30, 142–149 (2021).
doi: 10.1158/1055-9965.EPI-20-0944
Huang, J. et al. Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries. Cancers (Basel) 13, 141 (2021).
pubmed: 33466239
doi: 10.3390/cancers13010141
Global Burden of Disease Liver Cancer Collaboration. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 3, 1683–1691 (2017).
pmcid: 5824275
doi: 10.1001/jamaoncol.2017.3055
GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5, 582–597 (2020).
doi: 10.1016/S2468-1253(20)30007-8
Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol. Hepatol. 2, 161–176 (2017).
doi: 10.1016/S2468-1253(16)30181-9
Petrick, J. L. & McGlynn, K. A. The changing epidemiology of primary liver cancer. Curr. Epidemiol. Rep. 6, 104–111 (2019).
pubmed: 31259140
pmcid: 6599615
doi: 10.1007/s40471-019-00188-3
Wong, M. C. S. et al. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat. Rev. Gastroenterol. Hepatol. 16, 57–73 (2019).
pubmed: 30158570
doi: 10.1038/s41575-018-0055-0
Wong, V. W. et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 4, 1154–1161 (2006).
pubmed: 16904946
doi: 10.1016/j.cgh.2006.06.011
Ong, J. P., Pitts, A. & Younossi, Z. M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J. Hepatol. 49, 608–612 (2008).
pubmed: 18682312
doi: 10.1016/j.jhep.2008.06.018
Wong, V. W. et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 59, 969–974 (2010).
pubmed: 20581244
doi: 10.1136/gut.2009.205088
Lin, L. et al. The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the Global Burden of Disease Study 2017. Liver Cancer 9, 563–582 (2020).
pubmed: 33083281
pmcid: 7548973
doi: 10.1159/000508568
Lin, Y., Wang, H. L., Fang, K., Zheng, Y. & Wu, J. International trends in esophageal cancer incidence rates by histological subtype (1990–2012) and prediction of the rates to 2030. Esophagus https://doi.org/10.1007/s10388-022-00927-4 (2022).
doi: 10.1007/s10388-022-00927-4
pubmed: 35900684
Arnold, M., Laversanne, M., Brown, L. M., Devesa, S. S. & Bray, F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am. J. Gastroenterol. 112, 1247–1255 (2017).
pubmed: 28585555
doi: 10.1038/ajg.2017.155
Wang, Q. L., Xie, S. H., Wahlin, K. & Lagergren, J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clin. Epidemiol. 10, 717–728 (2018).
pubmed: 29950901
pmcid: 6016013
doi: 10.2147/CLEP.S166078
Wong, M. C. S. et al. Global incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci. Rep. 8, 4522 (2018).
pubmed: 29540708
pmcid: 5852053
doi: 10.1038/s41598-018-19819-8
Wong, M. C. S. et al. Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects. Eur. J. Epidemiol. 35, 673–683 (2020).
pubmed: 32448986
pmcid: 7387368
doi: 10.1007/s10654-020-00650-3
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. & Zwahlen, M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569–578 (2008).
pubmed: 18280327
doi: 10.1016/S0140-6736(08)60269-X
Steffen, A. et al. Anthropometry and esophageal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol. Biomark. Prev. 18, 2079–2089 (2009).
doi: 10.1158/1055-9965.EPI-09-0265
Lahmann, P. H., Pandeya, N., Webb, P. M., Green, A. C. & Whiteman, D. C. Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status? Cancer 118, 1901–1909 (2012).
pubmed: 21960146
doi: 10.1002/cncr.26455
Wong, M. C. et al. Worldwide incidence and prevalence of metabolic syndrome: a systematic review and meta-analysis of 14.6 million individuals [abstract TU1007]. Gastroenterology 158(6 Suppl. 1), S-1003 (2020).
doi: 10.1016/S0016-5085(20)33182-6
Lagergren, J., Bergström, R., Lindgren, A. & Nyrén, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825–831 (1999).
pubmed: 10080844
doi: 10.1056/NEJM199903183401101
Lagergren, J. Influence of obesity on the risk of esophageal disorders. Nat. Rev. Gastroenterol. Hepatol. 8, 340–347 (2011).
pubmed: 21643038
doi: 10.1038/nrgastro.2011.73
El-Serag, H. B., Sweet, S., Winchester, C. C. & Dent, J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63, 871–880 (2014).
pubmed: 23853213
doi: 10.1136/gutjnl-2012-304269
Wong, M. C. S. et al. Global incidence and mortality of gastric cancer, 1980–2018. JAMA Netw. Open 4, e2118457 (2021).
pubmed: 34309666
pmcid: 8314143
doi: 10.1001/jamanetworkopen.2021.18457
GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5, 42–54 (2020).
doi: 10.1016/S2468-1253(19)30328-0
Ouyang, G. et al. The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017. Cancer 127, 2238–2250 (2021).
pubmed: 33748947
doi: 10.1002/cncr.33476
Fock, K. M. & Ang, T. L. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J. Gastroenterol. Hepatol. 25, 479–486 (2010).
pubmed: 20370726
doi: 10.1111/j.1440-1746.2009.06188.x
Hipgrave, D. B., Chang, S., Li, X. & Wu, Y. Salt and sodium intake in China. JAMA 315, 703–705 (2016).
pubmed: 26881375
doi: 10.1001/jama.2015.15816
Inoue, M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer 20, 3–7 (2017).
pubmed: 27757699
doi: 10.1007/s10120-016-0658-5
Shimazu, T. et al. Association of vegetable and fruit intake with gastric cancer risk among Japanese: a pooled analysis of four cohort studies. Ann. Oncol. 25, 1228–1233 (2014).
pubmed: 24618149
doi: 10.1093/annonc/mdu115
Randi, G. et al. Epidemiology of biliary tract cancers: an update. Ann. Oncol. 20, 146–159 (2009).
pubmed: 18667395
doi: 10.1093/annonc/mdn533
Legorreta, A. P., Silber, J. H., Costantino, G. N., Kobylinski, R. W. & Zatz, S. L. Increased cholecystectomy rate after the introduction of laparoscopic cholecystectomy. JAMA 270, 1429–1432 (1993).
pubmed: 8371441
doi: 10.1001/jama.1993.03510120051029
Huang, X., Feng, Y. & Huang, Z. Complications of laparoscopic cholecystectomy in China: an analysis of 39,238 cases. Chin. Med. J. 110, 704–706 (1997).
pubmed: 9642330
Mohandas, K. M. & Patil, P. S. Cholecystectomy for asymptomatic gallstones can reduce gall bladder cancer mortality in northern Indian women. Indian. J. Gastroenterol. 25, 147–151 (2006).
pubmed: 16877830
Torre, L. A., Siegel, R. L., Islami, F., Bray, F. & Jemal, A. Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers. Clin. Gastroenterol. Hepatol. 16, 427–437 (2018).
pubmed: 28826679
doi: 10.1016/j.cgh.2017.08.017
Liao, J. K. Safety and efficacy of statins in Asians. Am. J. Cardiol. 99, 410–414 (2007).
pubmed: 17261409
doi: 10.1016/j.amjcard.2006.08.051
Bodmer, M., Brauchli, Y. B., Krähenbühl, S., Jick, S. S. & Meier, C. R. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA 302, 2001–2007 (2009).
pubmed: 19903921
doi: 10.1001/jama.2009.1601
Feletto, E. et al. Trends in colon and rectal cancer incidence in Australia from 1982 to 2014: analysis of data on over 375,000 cases. Cancer Epidemiol. Biomark. Prev. 28, 83–90 (2019).
doi: 10.1158/1055-9965.EPI-18-0523
Patel, P. & De, P. Trends in colorectal cancer incidence and related lifestyle risk factors in 15–49-year-olds in Canada, 1969–2010. Cancer Epidemiol. 42, 90–100 (2016).
pubmed: 27060626
doi: 10.1016/j.canep.2016.03.009
Larsen, I. K. & Bray, F. Trends in colorectal cancer incidence in Norway 1962-2006: an interpretation of the temporal patterns by anatomic subsite. Int. J. Cancer 126, 721–732 (2010).
pubmed: 19688825
doi: 10.1002/ijc.24839
di Martino, E. et al. Incidence trends for twelve cancers in younger adults–a rapid review. Br. J. Cancer 126, 1374–1386 (2022).
pubmed: 35132237
pmcid: 9090760
doi: 10.1038/s41416-022-01704-x
You, Y. N., Lee, L. D., Deschner, B. W. & Shibata, D. Colorectal cancer in the adolescent and young adult population. JCO Oncol. Pract. 16, 19–27 (2020).
pubmed: 32039664
pmcid: 7351341
doi: 10.1200/JOP.19.00153
Vuik, F. E. R. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 68, 1820–1826 (2019).
pubmed: 31097539
doi: 10.1136/gutjnl-2018-317592
Exarchakou, A., Donaldson, L. J., Girardi, F. & Coleman, M. P. Colorectal cancer incidence among young adults in England: trends by anatomical sub-site and deprivation. PLoS ONE 14, e0225547 (2019).
pubmed: 31805076
pmcid: 6894790
doi: 10.1371/journal.pone.0225547
Hur, H., Oh, C. M., Won, Y. J., Oh, J. H. & Kim, N. K. Characteristics and survival of Korean patients with colorectal cancer based on data from the Korea Central Cancer Registry Data. Ann. Coloproctol. 34, 212–221 (2018).
pubmed: 30208684
pmcid: 6140370
doi: 10.3393/ac.2018.08.02.1
Global Burden of Disease 2019 Cancer Collaboration. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 8, 420–444 (2022).
doi: 10.1001/jamaoncol.2021.6987
Alazmi, W. M., Siddique, I., Alateeqi, N. & Al-Nakib, B. Prevalence of Helicobacter pylori infection among new outpatients with dyspepsia in Kuwait. BMC Gastroenterol. 10, 14 (2010).
pubmed: 20128917
pmcid: 2835643
doi: 10.1186/1471-230X-10-14
Yim, J. Y. et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 12, 333–340 (2007).
pubmed: 17669107
doi: 10.1111/j.1523-5378.2007.00504.x
Pennathur, A., Gibson, M. K., Jobe, B. A. & Luketich, J. D. Oesophageal carcinoma. Lancet 381, 400–412 (2013).
pubmed: 23374478
doi: 10.1016/S0140-6736(12)60643-6
Kingham, T. P. et al. Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 14, e158–e167 (2013).
pubmed: 23561747
doi: 10.1016/S1470-2045(12)70472-2
Barton, M. B., Frommer, M. & Shafiq, J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol. 7, 584–595 (2006).
pubmed: 16814210
doi: 10.1016/S1470-2045(06)70759-8
Goss, P. E. et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 14, 391–436 (2013).
pubmed: 23628188
doi: 10.1016/S1470-2045(13)70048-2
Gini, A. et al. Impact of colorectal cancer screening on cancer-specific mortality in Europe: a systematic review. Eur. J. Cancer 127, 224–235 (2020).
pubmed: 31932176
doi: 10.1016/j.ejca.2019.12.014
Schreuders, E. H. et al. Colorectal cancer screening: a global overview of existing programmes. Gut 64, 1637 (2015).
pubmed: 26041752
doi: 10.1136/gutjnl-2014-309086
Araghi, M. et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int. J. Cancer 144, 2992–3000 (2019).
pubmed: 30536395
doi: 10.1002/ijc.32055
Ranganath, R. & Chu, Q. Global trends in pancreas cancer among Asia-Pacific population. J. Gastrointest. Oncol. 12, S374–S386 (2021).
pubmed: 34422401
pmcid: 8343088
doi: 10.21037/jgo-20-118
Dong, E., Duan, L. & Wu, B. U. Racial and ethnic minorities at increased risk for gastric cancer in a regional US population study. Clin. Gastroenterol. Hepatol. 15, 511–517 (2017).
pubmed: 27939654
doi: 10.1016/j.cgh.2016.11.033
Rawla, P. & Barsouk, A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz. Gastroenterol. 14, 26–38 (2019).
pubmed: 30944675
Nguyen, M. H. et al. Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clin. Gastroenterol. Hepatol. 2, 820–824 (2004).
pubmed: 15354283
doi: 10.1016/S1542-3565(04)00353-2
Zhang, G., Mai, R. & Huang, B. ADH1B Arg47His polymorphism is associated with esophageal cancer risk in high-incidence Asian population: evidence from a meta-analysis. PLoS ONE 5, e13679 (2010).
pubmed: 21048924
pmcid: 2965113
doi: 10.1371/journal.pone.0013679
Haggar, F. A. & Boushey, R. P. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin. Colon. Rectal Surg. 22, 191–197 (2009).
pubmed: 21037809
pmcid: 2796096
doi: 10.1055/s-0029-1242458
Chen, W. et al. Cancer incidence and mortality in China, 2014. Chin. J. Cancer Res. 30, 1–12 (2018).
pubmed: 29545714
pmcid: 5842223
doi: 10.21147/j.issn.1000-9604.2018.01.01
Tamakoshi, A. et al. Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project. J. Epidemiol. 27, S36–S42 (2017).
pubmed: 28214186
pmcid: 5350596
doi: 10.1016/j.je.2016.12.004
Jung, K.-W., Won, Y.-J., Kong, H.-J. & Lee, E. S. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res. Treat. 50, 303–316 (2018).
pubmed: 29566481
pmcid: 5912151
doi: 10.4143/crt.2018.143
Yuen, M. F., Hou, J. L. & Chutaputti, A. Hepatocellular carcinoma in the Asia pacific region. J. Gastroenterol. Hepatol. 24, 346–353 (2009).
pubmed: 19220670
doi: 10.1111/j.1440-1746.2009.05784.x
Nguyen, S. P., Bent, S., Chen, Y.-H. & Terdiman, J. P. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 7, 676–681.e3 (2009).
pubmed: 19514116
doi: 10.1016/j.cgh.2009.01.008
Newcomb, P. A. et al. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res. 67, 7534–7539 (2007).
pubmed: 17671225
doi: 10.1158/0008-5472.CAN-06-4275
Rossouw, J. E. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288, 321–333 (2002).
pubmed: 12117397
doi: 10.1001/jama.288.3.321
Xie, S. H. & Lagergren, J. The male predominance in esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 14, 338–347.e1 (2016).
pubmed: 26484704
doi: 10.1016/j.cgh.2015.10.005
Xie, S. H. et al. Circulating sex hormone levels and risk of esophageal adenocarcinoma in a prospective study in men. Am. J. Gastroenterol. 115, 216–223 (2020).
pubmed: 31658123
doi: 10.14309/ajg.0000000000000446
Chandanos, E. & Lagergren, J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur. J. Cancer 44, 2397–2403 (2008).
pubmed: 18755583
doi: 10.1016/j.ejca.2008.07.031
Derakhshan, M. H. et al. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut 58, 16–23 (2009).
pubmed: 18838486
doi: 10.1136/gut.2008.161331
Piehler, J. M. & Crichlow, R. W. Primary carcinoma of the gallbladder. Surg. Gynecol. Obstet. 147, 929–942 (1978).
pubmed: 362580
Bari, O. D. et al. Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment. Ann. Hepatol. 13, 728–745 (2014).
pubmed: 25332259
doi: 10.1016/S1665-2681(19)30975-5
Wistuba, I. I. & Gazdar, A. F. Gallbladder cancer: lessons from a rare tumour. Nat. Rev. Cancer 4, 695–706 (2004).
pubmed: 15343276
doi: 10.1038/nrc1429
Ng, S. C. et al. Increased risk of advanced neoplasms among asymptomatic siblings of patients with colorectal cancer. Gastroenterology 144, 544–550 (2013).
pubmed: 23159367
doi: 10.1053/j.gastro.2012.11.011
Choi, Y. J. & Kim, N. Gastric cancer and family history. Korean J. Intern. Med. 31, 1042–1053 (2016).
pubmed: 27809451
pmcid: 5094936
doi: 10.3904/kjim.2016.147
Liu, X. et al. Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population. Liver Int. 39, 1490–1503 (2019).
pubmed: 31228882
pmcid: 6705127
doi: 10.1111/liv.14182
Chen, T. et al. Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci. Rep. 5, 16038 (2015).
pubmed: 26526791
pmcid: 4630623
doi: 10.1038/srep16038
Wong, M. C. S. et al. Lower relative contribution of positive family history to colorectal cancer risk with increasing age: a systematic review and meta-analysis of 9.28 million individuals. Am. J. Gastroenterol. 113, 1819–1827 (2018).
pubmed: 29867176
pmcid: 6768593
doi: 10.1038/s41395-018-0075-y
Wong, M. C. et al. Risk of colorectal neoplasia in individuals with self-reported family history: a prospective colonoscopy study from 16 Asia-Pacific regions. Am. J. Gastroenterol. 111, 1621–1629 (2016).
pubmed: 26977757
doi: 10.1038/ajg.2016.52
Pourhoseingholi, M. A., Ashtari, S., Hajizadeh, N., Fazeli, Z. & Zali, M. R. Systematic review of pancreatic cancer epidemiology in Asia-Pacific region: major patterns in GLOBACON 2012. Gastroenterol. Hepatol. Bed Bench 10, 245–257 (2017).
pubmed: 29379588
pmcid: 5758731
Shi, C., Hruban, R. H. & Klein, A. P. Familial pancreatic cancer. Arch. Pathol. Lab. Med. 133, 365–374 (2009).
pubmed: 19260742
pmcid: 8281570
doi: 10.5858/133.3.365
Randi, G., Franceschi, S. & La Vecchia, C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int. J. Cancer 118, 1591–1602 (2006).
pubmed: 16397865
doi: 10.1002/ijc.21683
Gu, M. J. et al. Attributable causes of colorectal cancer in China. BMC Cancer 18, 38 (2018).
pubmed: 29304763
pmcid: 5756355
doi: 10.1186/s12885-017-3968-z
Tsong, W. H. et al. Cigarettes and alcohol in relation to colorectal cancer: the Singapore Chinese health study. Br. J. Cancer 96, 821–827 (2007).
pubmed: 17311023
pmcid: 2360085
doi: 10.1038/sj.bjc.6603623
Shimizu, N. et al. Height, weight and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br. J. Cancer 88, 1038–1043 (2003).
pubmed: 12671701
pmcid: 2376385
doi: 10.1038/sj.bjc.6600845
Koizumi, Y. et al. Cigarette smoking and the risk of gastric cancer: a pooled analysis of two prospective studies in Japan. Int. J. Cancer 112, 1049–1055 (2004).
pubmed: 15386347
doi: 10.1002/ijc.20518
Koh, W. P. et al. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br. J. Cancer 105, 1430–1435 (2011).
pubmed: 21915129
pmcid: 3241540
doi: 10.1038/bjc.2011.360
Yang, X. et al. Smoking and alcohol drinking in relation to the risk of esophageal squamous cell carcinoma: a population-based case-control study in China. Sci. Rep. 7, 17249 (2017).
pubmed: 29222520
pmcid: 5722909
doi: 10.1038/s41598-017-17617-2
Ansary-Moghaddam, A. et al. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol. Biomark. Prev. 15, 2435–2440 (2006).
doi: 10.1158/1055-9965.EPI-06-0368
Lugo, A., Peveri, G. & Gallus, S. Should we consider gallbladder cancer a new smoking-related cancer? A comprehensive meta-analysis focused on dose-response relationships. Int. J. Cancer 146, 3304–3311 (2020).
pubmed: 31513278
doi: 10.1002/ijc.32681
Naing, C., Lai, P. K. & Mak, J. W. Immediately modifiable risk factors attributable to colorectal cancer in Malaysia. BMC Public Health 17, 637 (2017).
pubmed: 28778191
pmcid: 5544995
doi: 10.1186/s12889-017-4650-8
Choi, Y. J. et al. The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population-based cohort study of South Korea. PLoS ONE https://doi.org/10.1371/journal.pone.0185778 (2017).
doi: 10.1371/journal.pone.0185778
pubmed: 29287074
pmcid: 5747431
Mizoue, T. et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am. J. Epidemiol. 167, 1397–1406 (2008).
pubmed: 18420544
doi: 10.1093/aje/kwn073
Li, Y. et al. Alcohol consumption and risk of gastric cancer: the Japan Collaborative Cohort Study. J. Epidemiol. 31, 30–36 (2021).
pubmed: 31902851
pmcid: 7738647
doi: 10.2188/jea.JE20190304
Yokoyama, A. & Omori, T. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn. J. Clin. Oncol. 33, 111–121 (2003).
pubmed: 12672787
doi: 10.1093/jjco/hyg026
Yokoyama, A. et al. Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19, 1383–1387 (1998).
pubmed: 9744533
doi: 10.1093/carcin/19.8.1383
Im, P. K. et al. Alcohol drinking and risks of total and site-specific cancers in China: a 10-year prospective study of 0.5 million adults. Int. J. Cancer 149, 522–534 (2021).
pubmed: 33634874
pmcid: 8359462
doi: 10.1002/ijc.33538
Shan, Y.-S. et al. No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol. Sci. Rep. 11, 14567 (2021).
pubmed: 34267279
pmcid: 8282609
doi: 10.1038/s41598-021-94111-w
Azeem, S. et al. Diet and colorectal cancer risk in Asia – a systematic review. Asian Pac. J. Cancer Prev. 16, 5389–5396 (2015).
pubmed: 26225683
doi: 10.7314/APJCP.2015.16.13.5389
Moore, M. A. Diverse influences of dietary factors on cancer in Asia. Asian Pac. J. Cancer Prev. 10, 981–986 (2009).
pubmed: 20192570
Chiu, B. C. H. et al. Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol. Biomark. Prev. 12, 201–208 (2003).
Park, Y., Lee, J., Oh, J. H., Shin, A. & Kim, J. Dietary patterns and colorectal cancer risk in a Korean population: a case-control study. Medicine 95, e3759 (2016).
pubmed: 27336862
pmcid: 4998300
doi: 10.1097/MD.0000000000003759
Lin, S. H., Li, Y. H., Leung, K., Huang, C. Y. & Wang, X. R. Salt processed food and gastric cancer in a Chinese population. Asian Pac. J. Cancer Prev. 15, 5293–5298 (2014).
pubmed: 25040991
doi: 10.7314/APJCP.2014.15.13.5293
Liu, Y. & Wu, F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Env. Health Perspect. 118, 818–824 (2010).
doi: 10.1289/ehp.0901388
Okada, E. et al. Dietary patterns and risk of esophageal cancer mortality: the Japan Collaborative Cohort Study. Nutr. Cancer 68, 1001–1009 (2016).
pubmed: 27366932
doi: 10.1080/01635581.2016.1192202
Nelson, S. M. et al. Diet and biliary tract cancer risk in Shanghai, China. PLoS ONE 12, e0173935 (2017).
pubmed: 28288186
pmcid: 5348031
doi: 10.1371/journal.pone.0173935
Zheng, J. et al. Dietary patterns and risk of pancreatic cancer: a systematic review. Nutr. Rev. 75, 883–908 (2017).
pubmed: 29025004
pmcid: 5914454
doi: 10.1093/nutrit/nux038
Liu, S.-Z. et al. Dietary factors and risk of pancreatic cancer: a multi-centre case-control study in China. Asian Pac. J. Cancer Prev. 15, 7947–7950 (2014).
pubmed: 25292092
doi: 10.7314/APJCP.2014.15.18.7947
Arafa, A. et al. Dairy intake and the risk of pancreatic cancer: the Japan Collaborative Cohort Study (JACC Study) and meta-analysis of prospective cohort studies. Br. J. Nutr. https://doi.org/10.1017/S0007114521004232 (2021).
doi: 10.1017/S0007114521004232
pubmed: 34666857
Mueller, N. T. et al. Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study. Cancer Epidemiol. Biomark. Prev. 19, 447–455 (2010).
doi: 10.1158/1055-9965.EPI-09-0862
Pham, N. M. et al. Physical activity and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn. J. Clin. Oncol. 42, 2–13 (2012).
pubmed: 22068300
doi: 10.1093/jjco/hyr160
Gunathilake, M. N. et al. Physical activity and gastric cancer risk in patients with and without Helicobacter pylori infection in a Korean population: a hospital-based case-control study. Cancers https://doi.org/10.3390/cancers10100369 (2018).
doi: 10.3390/cancers10100369
pubmed: 30279385
pmcid: 6210303
Inoue, M. et al. Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohort study in Japan. Am. J. Epidemiol. 168, 391–403 (2008).
pubmed: 18599492
doi: 10.1093/aje/kwn146
Etemadi, A. et al. Large body size and sedentary lifestyle during childhood and early adulthood and esophageal squamous cell carcinoma in a high-risk population. Ann. Oncol. 23, 1593–1600 (2012).
pubmed: 22052987
doi: 10.1093/annonc/mdr494
Wu, L. et al. Physical activity and pancreatic cancer risk among urban Chinese: results from two prospective cohort studies. Cancer Epidemiol. Biomark. Prev. 27, 479–487 (2018).
doi: 10.1158/1055-9965.EPI-17-0895
Pang, Y. et al. Association of physical activity with risk of hepatobiliary diseases in China: a prospective cohort study of 0.5 million people. Br. J. Sports Med. 55, 1024–1033 (2021).
pubmed: 32826226
doi: 10.1136/bjsports-2020-102174
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163 (2004).
doi: 10.1016/S0140-6736(03)15268-3
Matsuo, K. et al. Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan. Ann. Oncol. 23, 479–490 (2012).
pubmed: 21597097
doi: 10.1093/annonc/mdr143
Mafiana, R. N. et al. Association between dietary and lifestyle indices and colorectal cancer in Oman: a case-control study. Asian Pac. J. Cancer Prev. 19, 3117–3122 (2018).
pubmed: 30486551
pmcid: 6318402
doi: 10.31557/APJCP.2018.19.11.3117
Kim, H. J. et al. Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection. Gastric Cancer 18, 762–773 (2015).
pubmed: 25240409
doi: 10.1007/s10120-014-0429-0
Sohn, W. et al. Obesity and the risk of primary liver cancer: a systematic review and meta-analysis. Clin. Mol. Hepatol. 27, 157–174 (2021).
pubmed: 33238333
doi: 10.3350/cmh.2020.0176
Cho, J. H. et al. Abdominal obesity increases risk for esophageal cancer: a nationwide population-based cohort study of South Korea. J. Gastroenterol. 55, 307–316 (2020).
pubmed: 31792601
doi: 10.1007/s00535-019-01648-9
Hsing, A. W. et al. Body size and the risk of biliary tract cancer: a population-based study in China. Br. J. Cancer 99, 811–815 (2008).
pubmed: 18728671
pmcid: 2528141
doi: 10.1038/sj.bjc.6604616
Shin, C. M. et al. Association among obesity, metabolic health, and the risk for colorectal cancer in the general population in Korea using the National Health Insurance Service–National Sample Cohort. Dis. Colon Rectum 60, 1192–1200 (2017).
pubmed: 28991084
doi: 10.1097/DCR.0000000000000876
Li, F., Du, H., Li, S. & Liu, J. The association between metabolic syndrome and gastric cancer in Chinese. Front. Oncol. https://doi.org/10.3389/fonc.2018.00326 (2018).
doi: 10.3389/fonc.2018.00326
pubmed: 30719422
pmcid: 6308148
Yu, M.-W. et al. Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: a large cohort study. Gastroenterology 153, 1006–1017.e5 (2017).
pubmed: 28711626
doi: 10.1053/j.gastro.2017.07.001
Zhang, J., Wu, H. & Wang, R. Metabolic syndrome and esophageal cancer risk: a systematic review and meta-analysis. Diabetol. Metab. Syndr. 13, 8 (2021).
pubmed: 33468224
pmcid: 7816502
doi: 10.1186/s13098-021-00627-6
Ko, S. et al. Metabolic risk profile and cancer in Korean men and women. J. Prev. Med. Public. Health 49, 143–152 (2016).
pubmed: 27255073
pmcid: 4898898
doi: 10.3961/jpmph.16.021
[No authors listed] Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum. 61, 1–241 (1994).
Eslick, G. D., Lim, L. L.-Y., Byles, J. E., Xia, H. H.-X. & Talley, N. J. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am. J. Gastroenterol. 94, 2373–2379 (1999).
pubmed: 10483994
doi: 10.1111/j.1572-0241.1999.01360.x
Yang, L. et al. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study. Lancet Public Health 6, e888–e896 (2021).
pubmed: 34838195
pmcid: 8646857
doi: 10.1016/S2468-2667(21)00164-X
Ren, S. et al. Prevalence of Helicobacter pylori infection in China: a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 37, 464–470 (2022).
pubmed: 34862656
doi: 10.1111/jgh.15751
Fujisawa, T., Kumagai, T., Akamatsu, T., Kiyosawa, K. & Matsunaga, Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am. J. Gastroenterol. 94, 2094–2099 (1999).
pubmed: 10445533
doi: 10.1111/j.1572-0241.1999.01283.x
Hooi, J. K. Y. et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153, 420–429 (2017).
pubmed: 28456631
doi: 10.1053/j.gastro.2017.04.022
Mbulaiteye, S. M., Hisada, M. & El-Omar, E. M. Helicobacter pylori associated global gastric cancer burden. Front. Biosci. 14, 1490–1504 (2009).
pmcid: 2654592
doi: 10.2741/3320
Miwa, H., Go, M. F. & Sato, N. H. pylori and gastric cancer: the Asian enigma. Am. J. Gastroenterol. 97, 1106–1112 (2002).
pubmed: 12014714
doi: 10.1111/j.1572-0241.2002.05663.x
Zuo, Y. et al. Association between Helicobacter pylori infection and the risk of colorectal cancer: a systematic review and meta-analysis. Medicine 99, e21832 (2020).
pubmed: 32925719
pmcid: 7489651
doi: 10.1097/MD.0000000000021832
Hong, S. T. & Fang, Y. Clonorchis sinensis and clonorchiasis, an update. Parasitol. Int. 61, 17–24 (2012).
pubmed: 21741496
doi: 10.1016/j.parint.2011.06.007
Rim, H. J. Clonorchiasis: an update. J. Helminthol. 79, 269–281 (2005).
pubmed: 16153321
doi: 10.1079/JOH2005300
Na, B. K., Pak, J. H. & Hong, S. J. Clonorchis sinensis and clonorchiasis. Acta Trop. 203, 105309 (2020).
pubmed: 31862466
doi: 10.1016/j.actatropica.2019.105309
Bouvard, V. et al. A review of human carcinogens – Part B: biological agents. Lancet Oncol. 10, 321–322 (2009).
pubmed: 19350698
doi: 10.1016/S1470-2045(09)70096-8
Qian, M. B. et al. Familial assimilation in transmission of raw-freshwater fish-eating practice leading to clonorchiasis. PLoS Negl. Trop. Dis. 14, e0008263 (2020).
pubmed: 32352962
pmcid: 7233597
doi: 10.1371/journal.pntd.0008263
Qian, M.-B. et al. Effectiveness of health education in improving knowledge, practice and belief related to clonorchiasis in children. Acta Tropica 207, 105436 (2020).
pubmed: 32278640
doi: 10.1016/j.actatropica.2020.105436
Qian, M. B., Chen, Y. D., Liang, S., Yang, G. J. & Zhou, X. N. The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma. Infect. Dis. Poverty 1, 4 (2012).
pubmed: 23849183
pmcid: 3710150
doi: 10.1186/2049-9957-1-4
Shin, H. R. et al. Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea. J. Korean Med. Sci. 25, 1011–1016 (2010).
pubmed: 20592891
pmcid: 2890876
doi: 10.3346/jkms.2010.25.7.1011
Qian, M.-B. & Zhou, X.-N. Human liver flukes in China and ASEAN: time to fight together. PLoS Negl. Trop. Dis. 13, e0007214 (2019).
pubmed: 31022171
pmcid: 6483155
doi: 10.1371/journal.pntd.0007214
de Martel, C., Maucort-Boulch, D., Plummer, M. & Franceschi, S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 62, 1190–1200 (2015).
pubmed: 26146815
doi: 10.1002/hep.27969
World Health Organization. Global hepatitis report, 2017. WHO http://apps.who.int/iris/bitstream/10665/255017/1/WHO-HIV-2017.06-eng.pdf (2017).
Ott, J. J., Stevens, G. A., Groeger, J. & Wiersma, S. T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30, 2212–2219 (2012).
pubmed: 22273662
doi: 10.1016/j.vaccine.2011.12.116
Petruzziello, A., Marigliano, S., Loquercio, G., Cozzolino, A. & Cacciapuoti, C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J. Gastroenterol. 22, 7824–7840 (2016).
pubmed: 27678366
pmcid: 5016383
doi: 10.3748/wjg.v22.i34.7824
Lin, C. L. & Kao, J. H. Hepatitis B virus genotypes and variants. Cold Spring Harb. Perspect. Med. 5, a021436 (2015).
pubmed: 25934462
pmcid: 4448583
doi: 10.1101/cshperspect.a021436
Chen, Y. et al. Consumption of hot beverages and foods and the risk of esophageal cancer: a meta-analysis of observational studies. BMC Cancer 15, 449–449 (2015).
pubmed: 26031666
pmcid: 4457273
doi: 10.1186/s12885-015-1185-1
Hundal, R. & Shaffer, E. A. Gallbladder cancer: epidemiology and outcome. Clin. Epidemiol. 6, 99–109 (2014).
pubmed: 24634588
pmcid: 3952897
Singham, J., Schaeffer, D., Yoshida, E. & Scudamore, C. Choledochal cysts: analysis of disease pattern and optimal treatment in adult and paediatric patients. HPB 9, 383–387 (2007).
pubmed: 18345323
pmcid: 2225517
doi: 10.1080/13651820701646198
Stinton, L. M. & Shaffer, E. A. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 6, 172–187 (2012).
pubmed: 22570746
pmcid: 3343155
doi: 10.5009/gnl.2012.6.2.172
Rawla, P., Sunkara, T., Thandra, K. C. & Barsouk, A. Epidemiology of gallbladder cancer. Clin. Exp. Hepatol. 5, 93–102 (2019).
pubmed: 31501784
pmcid: 6728871
doi: 10.5114/ceh.2019.85166
Jabłońska, B. Biliary cysts: etiology, diagnosis and management. World J. Gastroenterol. 18, 4801–4810 (2012).
pubmed: 23002354
pmcid: 3447264
doi: 10.3748/wjg.v18.i35.4801
Kamisawa, T. et al. Japanese clinical practice guidelines for pancreaticobiliary maljunction. J. Gastroenterol. 47, 731–759 (2012).
pubmed: 22722902
doi: 10.1007/s00535-012-0611-2
Roa, I. et al. Clinicopathological features of gallbladder polyps and adenomas [Spanish]. Rev. Med. Chil. 132, 673–679 (2004).
pubmed: 15332368
Luu, H. N. et al. Quality diet index and risk of pancreatic cancer: findings from the Singapore Chinese Health Study. Cancer Epidemiol. Biomark. Prev. 30, 2068–2078 (2021).
doi: 10.1158/1055-9965.EPI-21-0033
Steck, S. E. & Murphy, E. A. Dietary patterns and cancer risk. Nat. Rev. Cancer 20, 125–138 (2020).
pubmed: 31848467
doi: 10.1038/s41568-019-0227-4
Yun, Y. H. et al. Dietary preference, physical activity, and cancer risk in men: National Health Insurance Corporation Study. BMC Cancer 8, 366 (2008).
pubmed: 19077256
pmcid: 2631012
doi: 10.1186/1471-2407-8-366
Wang, J. et al. Physically active individuals have a 23% lower risk of any colorectal neoplasia and a 27% lower risk of advanced colorectal neoplasia than their non-active counterparts: systematic review and meta-analysis of observational studies. Br. J. Sports Med. 54, 582 (2020).
pubmed: 31296585
doi: 10.1136/bjsports-2018-100350
Li, L., Assanangkornchai, S., Duo, L., McNeil, E. & Li, J. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012. PLoS ONE 9, e106899 (2014).
pubmed: 25203256
pmcid: 4159231
doi: 10.1371/journal.pone.0106899
Strosnider, H. et al. Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries. Env. Health Perspect. 114, 1898–1903 (2006).
doi: 10.1289/ehp.9302
Wang, Q.-L., Xie, S.-H., Li, W.-T. & Lagergren, J. Smoking cessation and risk of esophageal cancer by histological type: systematic review and meta-analysis. J. Natl Cancer Inst. 109, djx115 (2017).
doi: 10.1093/jnci/djx115
United Nations. Transforming our world: the 2030 agenda for sustainable development. United Nations https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf (2015).
La Torre, G. et al. Economic evaluation of HBV vaccination: a systematic review of recent publications (2000–2013). Hum. Vaccin. Immunother. 12, 2299–2311 (2016).
pubmed: 27105443
pmcid: 5027710
doi: 10.1080/21645515.2016.1166328
Luo, Z., Li, L. & Ruan, B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int. J. Infect. Dis. 16, e82–e88 (2012).
pubmed: 22178658
doi: 10.1016/j.ijid.2011.10.009
Sandhu, H. S., Roesel, S., Sharifuzzaman, M., Chunsuttiwat, S. & Tohme, R. A. Progress toward hepatitis B control–South-East Asia region, 2016-2019. MMWR Morb. Mortal. Wkly. Rep. 69, 988–992 (2020).
pubmed: 32730237
pmcid: 7392392
doi: 10.15585/mmwr.mm6930a2
Shan, S., Cui, F. & Jia, J. How to control highly endemic hepatitis B in Asia. Liver Int. 38 (Suppl 1), 122–125 (2018).
pubmed: 29427490
doi: 10.1111/liv.13625
Zhu, D. et al. Socioeconomic inequality in hepatitis B vaccination of rural adults in China. Hum. Vaccin. Immunother. 14, 464–470 (2018).
pubmed: 29072546
doi: 10.1080/21645515.2017.1396401
Ayers, J. W., Juon, H.-S., Lee, S. & Park, E. Hepatitis B vaccination prevalence and its predictors among Asian, Pacific Islander, Native American, and multiracial adults in the National Health and Nutrition Examination Survey. J. Immigr. Minor. Health 12, 847–852 (2010).
pubmed: 19967403
pmcid: 5508214
doi: 10.1007/s10903-009-9309-9
Beste, L. A., Green, P., Berry, K., Belperio, P. & Ioannou, G. N. Hepatitis C-related hepatocellular carcinoma incidence in the Veterans Health Administration after introduction of direct-acting antivirals. JAMA 324, 1003–1005 (2020).
pubmed: 32897335
pmcid: 7489813
doi: 10.1001/jama.2020.10121
Chang, L.-J. et al. Factors associated with the refusal of direct-acting antiviral agents for the treatment of hepatitis C in Taiwan. Medicina 58, 121 (2022).
doi: 10.3390/medicina58040521
Lee, Y. C. et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 150, 1113–1124.e5 (2016).
pubmed: 26836587
doi: 10.1053/j.gastro.2016.01.028
Yan, L. et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology https://doi.org/10.1053/j.gastro.2022.03.039 (2022).
doi: 10.1053/j.gastro.2022.03.039
pubmed: 36581813
pmcid: 9801670
Tshibangu-Kabamba, E. & Yamaoka, Y. Helicobacter pylori infection and antibiotic resistance–from biology to clinical implications. Nat. Rev. Gastroenterol. Hepatol. 18, 613–629 (2021).
pubmed: 34002081
doi: 10.1038/s41575-021-00449-x
Sung, J. J. et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 57, 1166–1176 (2008).
pubmed: 18628378
doi: 10.1136/gut.2007.146316
Sung, J. J. Y., Ng, S. C. & Chan, F. K. L. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut 64, 121–132 (2015).
pubmed: 24647008
doi: 10.1136/gutjnl-2013-306503
Ng, S. C. & Wong, S. H. Colorectal cancer screening in Asia. Br. Med. Bull. 105, 29–42 (2013).
pubmed: 23299409
doi: 10.1093/bmb/lds040
Yeoh, K. G. et al. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 60, 1236–1241 (2011).
pubmed: 21402615
doi: 10.1136/gut.2010.221168
Lee, B. I. et al. Korean guidelines for colorectal cancer screening and polyp detection. J. Korean Soc. Radiol. 66, 385 (2012).
doi: 10.3348/jksr.2012.66.4.385
Cancer Expert Working Group on Cancer Prevention and Screening. Recommendations on Prevention and Screening for Colorectal Cancer For Health Professionals. https://www.chp.gov.hk/files/pdf/cewg_crc_professional_hp.pdf (2022).
Huang, J. J. & Huang, J. L. Challenges to the adoption of risk algorithms for colorectal cancer screening programmes: perspectives for future research. Hong. Kong Med. J. 23, 661–663 (2017).
pubmed: 29226840
doi: 10.12809/hkmj177058
Wong, M. C. et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut 63, 1130–1136 (2014).
pubmed: 24045331
doi: 10.1136/gutjnl-2013-305639
Sung, J. J. Y. et al. A modified colorectal screening score for prediction of advanced neoplasia: a prospective study of 5744 subjects. J. Gastroenterol. Hepatol. 33, 187–194 (2018).
pubmed: 28561279
doi: 10.1111/jgh.13835
Hatamian, S., Hadavandsiri, F., Momenimovahed, Z. & Salehiniya, H. Barriers and facilitators of colorectal cancer screening in Asia. Ecancermedicalscience 15, 1285 (2021).
pubmed: 34824608
pmcid: 8580594
doi: 10.3332/ecancer.2021.1285
Wong, M. C. S. et al. Association of interactive reminders and automated messages with persistent adherence to colorectal cancer screening: a randomized clinical trial. JAMA Oncol. 3, 1281–1283 (2017).
pubmed: 28520919
pmcid: 5824284
doi: 10.1001/jamaoncol.2017.1062
Wong, M. C. et al. Effectiveness of reminder strategies on cancer screening adherence: a randomised controlled trial. Br. J. Gen. Pract. 68, e604–e611 (2018).
pubmed: 30104327
pmcid: 6104889
doi: 10.3399/bjgp18X698369
Kim, J. Y. et al. Development and validation of a scoring system for advanced colorectal neoplasm in young Korean subjects less than age 50 years. Intest. Res. https://doi.org/10.5217/ir.2018.00062 (2018).
doi: 10.5217/ir.2018.00062
pubmed: 30477283
pmcid: 6505089
Noh, C.-K. et al. Association of intensive endoscopic screening burden with gastric cancer detection. JAMA Netw. Open 4, e2032542 (2021).
pubmed: 33410877
pmcid: 7791358
doi: 10.1001/jamanetworkopen.2020.32542
Mabe, K. et al. Endoscopic screening for gastric cancer in Japan: current status and future perspectives. Dig. Endosc. 34, 412–419 (2022).
pubmed: 34143908
doi: 10.1111/den.14063
Chen, R. et al. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut 70, 251 (2021).
pubmed: 32241902
Hamashima, C. Benefits and harms of endoscopic screening for gastric cancer. World J. Gastroenterol. 22, 6385–6392 (2016).
pubmed: 27605874
pmcid: 4968120
doi: 10.3748/wjg.v22.i28.6385
Leung, C. Y. et al. Benefits and harms of gastric cancer screening and prevention in Japan: a microsimulation modeling analysis [abstract]. J. Glob. Oncol. 4 (Suppl. 2), 42s (2018).
doi: 10.1200/jgo.18.58700
World Health Organization. Cancer – Screening and early detection. WHO https://www.who.int/europe/news-room/fact-sheets/item/cancer-screening-and-early-detection-of-cancer#:~:text=Early%20diagnosis%20focuses%20on%20detecting,cancers%20before%20any%20symptoms%20appear (2010).
Leung, W. K. et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 9, 279–287 (2008).
pubmed: 18308253
doi: 10.1016/S1470-2045(08)70072-X
Wong, M. C. S. et al. Performance of screening tests for oesophageal squamous cell carcinoma: a systematic review and meta-analysis. Gastrointest. Endosc. https://doi.org/10.1016/j.gie.2022.04.005 (2022).
doi: 10.1016/j.gie.2022.04.005
pubmed: 36509113
Wong, M. C. S. & Huang, J. The growing burden of liver cirrhosis: implications for preventive measures. Hepatol. Int. 12, 201–203 (2018).
pubmed: 29679258
doi: 10.1007/s12072-018-9865-y
Zhang, L., Sanagapalli, S. & Stoita, A. Challenges in diagnosis of pancreatic cancer. World J. Gastroenterol. 24, 2047–2060 (2018).
pubmed: 29785074
pmcid: 5960811
doi: 10.3748/wjg.v24.i19.2047
Kongkam, P. et al. Pancreatic cancer in an Asian population. Endosc. Ultrasound 4, 56–62 (2015).
pubmed: 25789286
pmcid: 4362006
doi: 10.4103/2303-9027.151361
Dutta, U., Bush, N., Kalsi, D., Popli, P. & Kapoor, V. K. Epidemiology of gallbladder cancer in India. Chin. Clin. Oncol. 8, 33 (2019).
pubmed: 31484488
doi: 10.21037/cco.2019.08.03
Jefford, M. et al. Improved models of care for cancer survivors. Lancet 399, 1551–1560 (2022).
pubmed: 35430022
pmcid: 9009839
doi: 10.1016/S0140-6736(22)00306-3
Yoon, S. et al. Living with long-term consequences: experience of follow-up care and support needs among Asian long-term colorectal cancer survivors. Psychooncology 29, 1557–1563 (2020).
pubmed: 32596865
doi: 10.1002/pon.5452
Kim, H. & Yoo, Y.-S. Factors influencing supportive care needs of colorectal cancer survivors. Asian Nurs. Res. 15, 60–66 (2021).
doi: 10.1016/j.anr.2020.11.003
Jover, R. Surveillance after colonic neoplasia: to die of success. Endoscopy 45, 511–512 (2013).
pubmed: 23801311
doi: 10.1055/s-0033-1344154
Thinh, D. H. Q. et al. Analgesic prescription patterns and pain outcomes in Southeast Asia: findings from the analgesic treatment of cancer pain in Southeast Asia study. J. Glob. Oncol. 4, 1–10 (2018).
pubmed: 30241271
Emery, J. et al. Management of common clinical problems experienced by survivors of cancer. Lancet 399, 1537–1550 (2022).
pubmed: 35430021
doi: 10.1016/S0140-6736(22)00242-2
Kline, R. M. et al. Long-term survivorship care after cancer treatment–summary of a 2017 National Cancer Policy Forum Workshop. J. Natl Cancer Inst. 110, 1300–1310 (2018).
pubmed: 30496448
pmcid: 6658871
doi: 10.1093/jnci/djy176